Navigation Links
Biomarker Combination and Risk of Ovarian Malignancy Algorithm (Roma(TM)) Demonstrates Accuracy in Detecting Ovarian Cancer
Date:2/11/2009

n Providence, RI. "By using a test with greater accuracy that is not reliant on subjective imaging, physicians can now identify those patients that are at a high risk for having a malignancy, potentially improving clinical outcomes for these women."

Dr. Moore presented data from a prospective, double-blind, multicenter trial of 457 evaluable women diagnosed with a pelvic mass. Blood samples were obtained from study participants to measure for levels of HE4 and CA125. Two separate algorithms for premenopausal (n=212) and postmenopausal (n=245) women stratified patients into low- and high-risk groups. All patients then underwent surgical removal of the pelvic mass, and if a patient was diagnosed with an EOC, surgical staging was required by protocol. All tissue specimens were examined to verify the diagnoses made by study site pathologists.

There were 123 patients determined to have an invasive EOC and 22 patients had a low malignant potential or borderline tumor. The remainder had various benign tumors. ROMA stratified 94.3% of the women with an invasive EOC correctly into a high-risk group.

Additionally, ROMA demonstrated greater accuracy in detecting ovarian cancer across all stages of disease, including early stage disease where 85.3% of the invasive EOCs were correctly identified.

"Currently, only 20% of women with ovarian cancer are diagnosed in the early stages, when the five-year life expectancy exceeds 90%," commented Dr. Moore, who is also the Director of Medical Education for the Program in Women's Oncology and a gynecologic oncologist at Women & Infants' Hospital in Providence, RI.

About HE4

HE4 in a manual format is currently FDA-cleared for monitoring recurrent or progressive disease in patients with EOC, and CE-marked in Europe as an aid in estimating the risk of EOC in premenopausal or postmenopausal women presenting with a pelvic mass. T
'/>"/>

SOURCE Fujirebio Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MDS Analytical Technologies Laser Capture Microdissection Helps Facilitate Discovery of Potential New Colon-Cancer Biomarker
2. Frost & Sullivan Lauds Toscana Biomarkers Outstanding Contributions to the R&D of Novel Biomarkers for the Diagnosis of Autoimmune Diseases
3. Thomson Reuters White Paper Explores the Role of Biomarkers in Clinical Trials and Drug Development
4. Biomarkers improve ischemic stroke prediction
5. Biomarkers: What can they tell us
6. PreMD Files Provisional Patent Application Describing a New Method of Quantifying Cancer Biomarkers
7. Common painkillers lower levels of prostate cancer biomarker
8. Biomarkers May Help Spot, Track Alzheimers
9. Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes
10. Elevated biomarkers predict risk for prostate cancer recurrence
11. Pancreatic Cancer Biomarkers Found
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Milton Hershey School® graduate Vincent Klomps ’10 ... of the Physician Assistant Program’s entering class of 2015 ... with a white coat, which symbolizes his entrance into ... of Vincent’s accomplishments both at MHS and postgraduation,” said ... of how a top-notch education can lead to achievement ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 ANT Wireless, ... the market entry of two new products implementing the ... Trainer announce new wireless interoperability in their bike trainer ... for cyclists. Tacx has implemented the FE-C device profile ... as well as its new indoor training software, while ...
(Date:6/2/2015)... MAP Health Management, LLC, a provider of outcome data, ... facilities, announced today that Jared Smith has joined the ... be responsible for developing and implementing a marketing strategy ... message, products and initiatives. , Prior to joining MAP, ... in Irving, Texas, where he was responsible for developing ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 DiaTech ... drug response profiling test to help oncologists provide ... College of American Pathologists (CAP) for its laboratories ... CAP certification is equivalent to the ‘Good Housekeeping’ ... and chief executive officer for DiaTech. “It’s a ...
(Date:6/2/2015)... 2015 For those that have ever ... to harmful germs, chemicals and bodily fluids from each ... an inventor from Queens Village, N.Y., their worries are ... efficient, fun, hygienic way to store and dispense toothpaste. ... bugs, chemicals and germs. Furthermore, it insures that all ...
Breaking Medicine News(10 mins):Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:DiaTech Oncology Gains College of American Pathologists Accreditation for U.S. CorrectChemo Laboratory 2Health News:Dental Storage and Dispensing Unit Invented by InventHelp Client (LGI-1890) 2
... GE Healthcare, the leading manufacturer of 3D/4D ultrasound ... Virginia Medical School (EVMS) obstetrician that can automate the ... fetal heart defects. GE Healthcare has licensed the software ... Alfred Abuhamad, M.D., chairman of obstetrics and gynecology at ...
... Communication and Compliance Important for Addressing ... Challenges Uncovered in Survey, AVENTURA, Fla., ... (UC) consider feeling unwell to be a,normal part of life, while ... UC patients, according to results from a,nationwide series of surveys presented ...
... First Oral Pharmacologic Agent Developed for the Treatment of Premature ... ... 7 Janssen-Cilag companies in,Europe have submitted a Marketing Authorisation Application ... years,of age., Premature ejaculation is a form of male sexual ...
... more than half, CDC study finds , FRIDAY, Dec. ... receiving the pneumococcal vaccine appears to be associated with ... to a new report from the U.S. Centers for ... 7-valent pneumococcal conjugate vaccine (PDV7) became part of the ...
... battle in fighting heart disease, ... Health Corp. CEO Gary Stanton., MELBOURNE, Fla., Dec. 7 ... heart disease all,in one Natural product. Lowering unhealthy cholesterol levels is ... build up of,plaque in the arteries and the heart muscle itself. ...
... AstraZeneca,CEO, and senior management from AstraZeneca (LSE: AZN) ... the biologics field, R&D and portfolio,progress plus the ... are available now on http://www.cantos.com ., ... do is register at, http://www.cantos.com ., Cantos.com ...
Cached Medicine News:Health News:Procedure to detect fetal heart defects is first automated use of 3-D ultrasound 2Health News:Procedure to detect fetal heart defects is first automated use of 3-D ultrasound 3Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 2Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 3Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 4Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 5Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 6Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 7Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 8Health News:Submission of Marketing Authorisation Application for Dapoxetine in Europe 2Health News:Pneumonia Vaccine Is Keeping Kids Healthier 2Health News:New Health Corp. Introduces Heart Savior(TM), the Ultimate Natural Heart Health Product 2
(Date:6/2/2015)... , June 2, 2015 ... and segments the concerned market with analysis and ... $261.8 million in 2014, and is estimated to ... of 19.3% from 2014 to 2019. ... Simulation Market for an analysis of industry trends ...
(Date:6/2/2015)... , June 2, 2015 BioDelivery Sciences International, Inc. ... the presentation by Dr. Mark A. Sirgo , President ... 2:30 PM Eastern time. Jefferies 2015 Global Healthcare ... Hyatt, New York City , NY ... accessed at www.bdsi.com .  For those who are not ...
(Date:6/2/2015)... -- Only a quarter of physicians who prescribe opioids say ... them to, according to new survey results released by ... and myCME , Haymarket Medical Education,s global medical ... director of BUSM,s Safe and Competent Opioid Prescribing ... a critical need for provider education addressing this issue. ...
Breaking Medicine Technology:North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3Survey Results Show Few Doctors Are Very Confident Managing Patients on Opioids 2
... ... Jolla-, ... /PRNewswire-,FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a,biopharmaceutical company ... organization, today announced,that an agreement has been executed licensing classes of ...
... The Quigley,Corporation (Nasdaq: QGLY ) announced positive ... subsidiary, Quigley Pharma Inc., which was,conducted in chickens ... The compound was administered to chicks that had ... from the study indicated,that QR448(a) is efficacious against ...
Cached Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: